作者单位:
From the Yale University School of Medicine, New Haven, CT (E.M.B.); Department of Chronic Disease Epidemiology (E.M.B.) and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, and the Department of Health Policy and Management (H.M.K.), Yale School of Public Health, New Haven, CT; Department of Internal Medicine, Massachusetts General Hospital, Boston (S.S.R., N.M.B.); Center for Outcomes Research and Evaluation, Yale University, New Haven, CT (R.P.D., H.M.K.); and Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (A.J.L., H.M.K.).
[1]
From the Yale University School of Medicine, New Haven, CT (E.M.B.); Department of Chronic Disease Epidemiology (E.M.B.) and Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, and the Department of Health Policy and Management (H.M.K.), Yale School of Public Health, New Haven, CT; Department of Internal Medicine, Massachusetts General Hospital, Boston (S.S.R., N.M.B.); Center for Outcomes Research and Evaluation, Yale University, New Haven, CT (R.P.D., H.M.K.); and Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT (A.J.L., H.M.K.). harlan.krumholz@yale.edu.
[2]
DOI
10.1161/CIRCULATIONAHA.114.009480
PMID
25052403
发布时间
2022-03-17